Methamphetamine generates peroxynitrite and produces dopaminergic neurotoxicity in mice: Protective effects of peroxynitrite decomposition catalyst

Brain Research

Volumn 837, Issue 1-2, 1999, Pages 15-21

  Imam, Syed Z ^a,b   Crow, John P ^c   Newport, Glenn D ^a   Islam, Fakhrul ^b   Slikker Jr , William ^a   Ali, Syed F ^a  

^a Natl Ctr Toxicological Res F   (United States)

^b Neurotoxicology Laboratory   (India)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

3 Nitrotyrosine; Dopamine; Methamphetamine; Oxidative stress; Peroxynitrite; Striatum

Indexed keywords

3 NITROTYROSINE; 3,4 DIHYDROXYPHENYLACETIC ACID; DOPAMINE; HOMOVANILLIC ACID; METHAMPHETAMINE; PEROXYNITRITE;

ANIMAL MODEL; ARTICLE; BODY TEMPERATURE; CATALYST; CONTROLLED STUDY; DOPAMINE METABOLISM; DOPAMINERGIC SYSTEM; DRUG ABUSE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIPID PEROXIDATION; MALE; MOUSE; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL;

3,4-DIHYDROXYPHENYLACETIC ACID; ANIMALS; BODY TEMPERATURE; CORPUS STRIATUM; DOPAMINE; HOMOVANILLIC ACID; MALE; METHAMPHETAMINE; MICE; MICE, INBRED C57BL; NEUROPROTECTIVE AGENTS; NEUROTOXINS; NITRATES; OXIDANTS; PORPHYRINS; REFERENCE VALUES; TYROSINE;

EID: 0033533081     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(99)01663-7     Document Type: Article

References (41)

1. Abekawa T., Ohmori T., Koyama T. Effect of nitric oxide synthesis inhibition on methamphetamine-induced dopaminergic and serotonergic neurotoxicity in rat brain. J. Neural Transm. 103:1996;671-680.
2. Ali S.F., Newport G.D., Holson R.R., Slikker W. Jr., Bowyer J.F. Low environmental temperature or pharmacologic agents that produce hypothermia decrease methamphetamine neurotoxicity in mice. Brain Res. 658:1994;33-38.
3. Ara J., Przedborski S., Ali B.N., Jackson-Lewis V., Trifiletti R.R., Horwitz J., Ischiropoulos H. Inactivation of tyrosine hydroxylase by nitration following exposure to peroxynitrite and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Proc. Natl. Acad. Sci. U.S.A. 95:1998;7659-7663.
4. Beckman J.S., Chen J., Ischiropoulos H., Crow J.P. Oxidative chemistry of peroxynitrite. Methods Enzymol. 223:1994;229-240.
5. Bowyer J.F., Tank A.W., Newport G.D., Slikker W. Jr., Ali S.F., Holson R.R. The influence of environmental temperature on the transient effects of methamphetamine on dopamine levels and dopamine release in rat striatum. J. Pharmacol. Exp. Ther. 260:1992;817-824.
6. Cadet J.L., Brannock C. Free radicals and the pathobiology of brain dopamine system. Neurochem. Int. 32:1998;117-131.
7. Cadet J.L., Ali S.F., Rothman R.B., Epstein C.J. Neurotoxicity, drugs of abuse, and the CuZn-superoxide dismutase in transgenic mice. Mol. Neurobiol. 11:1995;155-163.
8. Cadet J.L., Sheng P., Ali S.F., Rothman R.B., Carlson E., Epstein C.J. Attenuation of methamphetamine-induced neurotoxicity in copper/zinc superoxide dismutase in transgenic mice. J. Neurochem. 62:1994;380-383.
9. Crow J.P. Measurement and significance of free and protein-bound nitrotyrosine, 3-chlorotyrosine, and free 3-nitro-4-hydroxyphenylacetic acid in biologic samples: an HPLC method using electrochemical detection. Methods Enzymol. 301:1998;151-160.
10. Di Monte D.A., Royland J.E., Jakowec M.W., Langston J.W. Role of nitric oxide in methamphetamine neurotoxicity: protection by 7-nitroindazole, an inhibitor of neuronal nitric oxide synthase. J. Neurochem. 67:1996;2443-2450.
11. Garthwaite J. Glutamate, nitric oxide and cell-cell signaling. Trends Neurosci. 14:1991;60-67.
12. Hantraye P., Brouillet E., Ferrante R., Palfi S., Dolan R., Matthews R.T., Beal M.F. Inhibition of neuronal nitric oxide synthase prevents MPTP-induced parkinsonism in baboons. Nat. Med. 2:1996;1017-1021.
13. Hirata H.H., Ladenheim B., Carlson E., Epstein C., Cadet J.L. Autoradiographic evidence for methamphetamine-induced striatal dopaminergic loss in mouse brain: attenuation in CuZn-superoxide dismutase transgenic mice. Brain Res. 714:1996;95-103.
14. Hooper D.C., Bagsara O., Marini J.C., Zborek A., Ohnishi S.T., Kean R., Champion J.M., Sarker A.B., Bobroski L., Farber J.L., Akaike T., Maeda H., Koprowski H. Prevention of experimental allergic encephalomyelitis by targeting nitric oxide and peroxynitrite: implications for the treatment of multiple sclerosis. Proc. Natl. Acad. Sci. U.S.A. 94:1997;2528-2533.
15. Hunt J.A., Lee J., Groves J.T. Amphiphilic peroxynitrite decomposition catalysts in liposomal assemblies. Chem. Biol. 4:1997;845-858.
16. Imam S.Z., Newport G.D., Islam F., Slikker W. Jr., Ali S.F. Selenium, an antioxidant, protects against methamphetamine-induced dopaminergic neurotoxicity. Brain Res. 818:1999;575-578.
17. Ischiropoulos H., Zhu L., Beckman J.S. Peroxynitrite formation from macrophage-derived nitric oxide. Arch. Biochem. Biophys. 298:1992;446-451.
18. Itzhak Y., Ali S.F. The neuronal nitric oxide synthase inhibitor, 7-nitroindazole, protect against methamphetamine-induced neurotoxicity in vivo. J. Neurochem. 67:1996;1770-1773.
19. Itzhak Y., Martin J.L., Black D.M., Ali S.F. Effects of melatonin on methamphetamine and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity and methamphetamine-induced behavioral sensitization. Neuropharmacology. 37:1998;781-791.
20. Itzhak Y., Gandia C., Huang P.L., Ali S.F. Resistance to neuronal nitric oxide synthase deficient mice to methamphetamine-induced dopaminergic neurotoxicity in vivo. J. Pharmacol. Exp. Ther. 284:1998;1040-1047.
21. Y. Itzhak, J.L. Martin, S.F. Ali, Methamphetamine- and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity in inducible nitric oxide synthase-deficient mice. Synapse, 1999, in press.
22. Karler R., Chaudhry I.A., Calder L.D., Turkanis S.A. Amphetamine behavioral sensitization and excitatory amino acids. Brain Res. 537:1990;76-82.
23. Kogan F.J., Nichols W.K., Gibb J.W. Influence of methamphetamine on nigral and striatal tyrosine hydroxylase activity and on dopamine depletion. Eur. J. Pharmacol. 36:1976;363-371.
24. Miller D.B., O'Callaghan J.P. Environmental-, drug- and stress-induced alterations in body temperature affect the neurotoxicity of substituted amphetamine in the C57BL/6J mouse. J. Pharmacol. Exp. Ther. 270:1994;752-760.
25. Misko T.P., Highkin M.K., Veenhuizen A.W., Manning P.T., Stern M.K., Currie M.G., Salvemini D. Characterization of cytoprotective action of peroxynitrite decomposition catalysts. J. Biol. Chem. 273:1998;15646-15653.
26. Nash J.F., Yamamoto B.K. Methamphetamine neurotoxicity and glutamate release: comparison to 3,4-methylenedioxymethamphetamine. Brain Res. 581:1992;237-243.
27. Przedborski S., Jackson-Lewis V., Yokoyama R., Shibata T., Dawson V.L., Dawson T.M. Role of neuronal nitric oxide synthase in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity. Proc. Natl. Acad. Sci. U.S.A. 93:1996;4565-4571.
28. Radi R., Beckman J.S., Bush K.M., Freeman B.A. Peroxynitrite oxidation of sulfhydryls. The cytotoxic potential of superoxide and nitric oxide. J. Biol. Chem. 266:1991;4244-4250.
29. Radi R., Beckman J.S., Bush K.M., Freeman B.A. Peroxynitrite-induced membrane lipid peroxidation: the cytotoxic potential of superoxide and nitric oxide. Arch. Biochem. Biophys. 288:1991;481-487.
30. Rubbo H., Radi R., Trujillo M., Teller R., Kalyanaraman B., Barnes S., Kirk M., Freeman B.A. Nitric oxide regulation of superoxide and peroxynitrite-dependent lipid peroxidation: formation of novel nitrogen-containing lipid derivatives. J. Biol. Chem. 269:1994;26066-26075.
31. Salvemini D., Wang Z., Stern M.K., Currie M.G., Misko T.P. Peroxynitrite decomposition catalysts: therapeutics for peroxynitrite-mediated pathology. Proc. Natl. Acad. Sci. U.S.A. 95:1998;2659-2663.
32. Schultz J.B., Matthews R.T., Muqit M.M., Browne S.E., Beal M.F. Inhibition of neuronal nitric oxide synthase by 7-nitroindazole protects against MPTP-induced neurotoxicity in mice. J. Neurochem. 64:1995;936-939.
33. Sieden L.S., Fischman M.W., Schuster C.R. Long-term methamphetamine-induced changes in brain catecholamines in tolerant rhesus monkeys. Drug Alcohol Depend. 1:1975;215-219.
34. Sheng P., Cerruti C., Ali S.F., Cadet J.L. Nitric oxide is a mediator of methamphetamine-induced neurotoxicity: in vitro evidence from primary cultures of mesencephalic cells. Ann. New York Acad. Sci. 801:1996;174-187.
35. Smith P.K., Krohn R.I., Hermanson G.T., Mallia A.K., Gartner F.H. Measurement of protein using bicinchoninic acid. Anal. Biochem. 150:1985;76-85.
36. Sonsalla P.K., Nicklas W.J., Heikkila R.E. Role of excitatory amino acids in methamphetamine-induced nigrostriatal dopaminergic toxicity. Science. 243:1989;398-400.
37. Stern M.K., Jensen M.P., Kramer K. Peroxynitrite decomposition catalysts. J. Am. Chem. Soc. 118:1996;8735-8736.
38. van der Vliet A., O'Neill C.A., Halliwell B., Cross C.E., Kaur H. Aromatic hydroxylation and nitration of phenylalanine and tyrosine by peroxynitrite: evidence for hydroxyl radical production from peroxynitrite. FEBS Lett. 339:1994;89-92.
39. van der Vliet A., Eiserich J.P., O'Neill C.A., Halliwell B., Cross C.E. Tyrosine modification by reactive nitrogen species: a closer look. Arch. Biochem. Biophys. 319:1995;341-349.
40. Weihmuller F.B., O'Dell S.J., Marshall J.F. MK-801 protection against methamphetamine-induced striatal dopamine terminal injury is associated with attenuated dopamine overflow. Synapse. 11:1992;155-163.
41. Wilson J.M., Kalasinsky K.S., Levey A.I., Bergeron C., Reiber G., Anthony R.M., Schmunk G.A., Shannak K., Haycock J.W., Kish S.J. Striatal dopamine nerve terminal markers in human chronic methamphetamine users. Nat. Med. 2:1996;699-703.